Hero

African Cohort Study (AFRICOS)

In 2013, MHRP initiated the African Cohort Study (AFRICOS), the first of its kind in sub-Saharan Africa. AFRICOS is a large long-term observational cohort study in Kenya, Nigeria, Tanzania, and Uganda. AFRICOS participants are enrolled from health facility clinic patient populations and allows for the unparalleled longitudinal characterization of the HIV epidemic in the African context, tracking the impact of clinical practices, biological factors and socio-behavioral issues on HIV and disease progression.  AFRICOS findings influence host-nation HIV policy and PEPFAR programming by providing data for evidence-based guidelines and interventions.

Spotlight

MHRP's African Cohort Study (AFRICOS), is a longitudinal observational cohort study that is able to answer key questions surrounding people living with HIV in sub-Saharan Africa. The AFRICOS team worked with the Global Health Security and Diplomacy (GHSD) U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Ambassador Dr. John Nkengasong and Chief Science Officer, Dr. Mike Reid, to develop and publish a manuscript summarizing key findings and highlighting the transformative impact of this cohort and how AFRICOS has contributed to the HIV 95-95-95 goals in sub-Saharan Africa.